High-Risk Cardiovascular Patients: Clinical Features, Comorbidities, and Interconnecting Mechanisms

Area of Science:

• Cardiovascular Medicine
• Immunology
• Pathophysiology

Background:

• Cardiovascular disease (CVD) is the primary cause of mortality globally, with atherosclerosis underlying major events like myocardial infarction and stroke.
• Recent understanding highlights inflammation and inflammatory processes within the vessel wall as key drivers of atherogenesis.
• Subclinical inflammation, present in conditions such as diabetes and chronic inflammatory diseases (e.g., rheumatoid arthritis), is a significant risk factor for CVD.

Purpose of the Study:

• To review the inflammatory processes in the vessel wall that lead to atherosclerosis.
• To emphasize the critical role of inflammation in the cardiovascular morbidity and mortality associated with diabetes and chronic inflammatory diseases.

Main Methods:

• This is a review article.
• It synthesizes current knowledge on the pathophysiology of atherosclerosis and inflammation.
• It examines the link between systemic inflammatory conditions and cardiovascular outcomes.

Main Results:

• Inflammation is integral to the development and progression of atherosclerosis.
• Diabetes and chronic inflammatory diseases significantly increase cardiovascular risk due to heightened inflammatory states.
• Understanding these inflammatory pathways offers potential therapeutic targets.

Conclusions:

• Inflammation is a central mechanism in atherosclerosis and a major contributor to cardiovascular disease.
• Managing inflammation in patients with diabetes and chronic inflammatory diseases is crucial for reducing cardiovascular risk.
• Further research into anti-inflammatory strategies may mitigate CVD burden.